Matches in SemOpenAlex for { <https://semopenalex.org/work/W10393505> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W10393505 endingPage "33" @default.
- W10393505 startingPage "28" @default.
- W10393505 abstract "The term thrombotic microangiopathy (TMA) encompasses syndromes of thrombocytopenia, microangiopathic haemolytic anaemia, neurologic deficits, renal dysfunction and variable signs of organ impairment. Childhood cases of TMA with predominant renal failure are usually referred as Haemolytic Uremic Syndrome (HUS), and adult cases with major neurological involvement as Thrombotic Thrombocytopenic Purpura (TTP). Exotoxins, produced in most cases by E. Coli O 157:H7, have been related to diarrhea associated HUS(D + HUS). Anticancer (mitomycin), immunosuppressive drugs (cyclosporin, tacrolimus and OKT3) and as well as some antiplatelet agents (ticlopidine, clopidrogel) have been associated with both HUS and TTP. Defective factor H or vWF protease activity have been found with familiar and recurrent forms. Endothelial damage and dysfunction is most likely the initial event of the pathogenic process that eventually leads to platelet aggregation, microvascular thrombosis and tissue ischemia. TMA may occur de novo in the native kidneys of patients who received a non-kidney transplant or in the transplanted kidney of patients who progressed to ESRD because of a disease other than HUS. Calcineurin inhibitors and vascular rejection are most often involved in these cases. The disease may also recur on the transplanted kidney in patients who progressed to ESRD because of HUS/TTP. The risk of postransplant recurrence is negligible for D + HUS but is close to 100% in familial/recurrent forms associated with low C3 and decreased factor H bioavailability or activity. Withdrawal or treatment of precipitating factors are the most effective approach. Plasma therapy is usually attempted with the rationale to limit the microangiopathic process, but its efficacy for improving graft survival is unproven. The outcome of recurrent forms is almost invariably poor." @default.
- W10393505 created "2016-06-24" @default.
- W10393505 creator A5011057274 @default.
- W10393505 creator A5067635660 @default.
- W10393505 creator A5076316519 @default.
- W10393505 date "2002-01-01" @default.
- W10393505 modified "2023-09-23" @default.
- W10393505 title "Thrombotic microangiopathy in renal transplantation." @default.
- W10393505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12221901" @default.
- W10393505 hasPublicationYear "2002" @default.
- W10393505 type Work @default.
- W10393505 sameAs 10393505 @default.
- W10393505 citedByCount "14" @default.
- W10393505 countsByYear W103935052012 @default.
- W10393505 countsByYear W103935052014 @default.
- W10393505 countsByYear W103935052016 @default.
- W10393505 countsByYear W103935052020 @default.
- W10393505 countsByYear W103935052023 @default.
- W10393505 crossrefType "journal-article" @default.
- W10393505 hasAuthorship W10393505A5011057274 @default.
- W10393505 hasAuthorship W10393505A5067635660 @default.
- W10393505 hasAuthorship W10393505A5076316519 @default.
- W10393505 hasConcept C126322002 @default.
- W10393505 hasConcept C128057223 @default.
- W10393505 hasConcept C134018914 @default.
- W10393505 hasConcept C203014093 @default.
- W10393505 hasConcept C2776513394 @default.
- W10393505 hasConcept C2777878052 @default.
- W10393505 hasConcept C2778585876 @default.
- W10393505 hasConcept C2778653478 @default.
- W10393505 hasConcept C2779134260 @default.
- W10393505 hasConcept C2780091579 @default.
- W10393505 hasConcept C2780921031 @default.
- W10393505 hasConcept C2781127562 @default.
- W10393505 hasConcept C2909675724 @default.
- W10393505 hasConcept C2911091166 @default.
- W10393505 hasConcept C555293320 @default.
- W10393505 hasConcept C71924100 @default.
- W10393505 hasConcept C89560881 @default.
- W10393505 hasConcept C90924648 @default.
- W10393505 hasConceptScore W10393505C126322002 @default.
- W10393505 hasConceptScore W10393505C128057223 @default.
- W10393505 hasConceptScore W10393505C134018914 @default.
- W10393505 hasConceptScore W10393505C203014093 @default.
- W10393505 hasConceptScore W10393505C2776513394 @default.
- W10393505 hasConceptScore W10393505C2777878052 @default.
- W10393505 hasConceptScore W10393505C2778585876 @default.
- W10393505 hasConceptScore W10393505C2778653478 @default.
- W10393505 hasConceptScore W10393505C2779134260 @default.
- W10393505 hasConceptScore W10393505C2780091579 @default.
- W10393505 hasConceptScore W10393505C2780921031 @default.
- W10393505 hasConceptScore W10393505C2781127562 @default.
- W10393505 hasConceptScore W10393505C2909675724 @default.
- W10393505 hasConceptScore W10393505C2911091166 @default.
- W10393505 hasConceptScore W10393505C555293320 @default.
- W10393505 hasConceptScore W10393505C71924100 @default.
- W10393505 hasConceptScore W10393505C89560881 @default.
- W10393505 hasConceptScore W10393505C90924648 @default.
- W10393505 hasIssue "1" @default.
- W10393505 hasLocation W103935051 @default.
- W10393505 hasOpenAccess W10393505 @default.
- W10393505 hasPrimaryLocation W103935051 @default.
- W10393505 hasRelatedWork W10393505 @default.
- W10393505 hasRelatedWork W2012585132 @default.
- W10393505 hasRelatedWork W2092127489 @default.
- W10393505 hasRelatedWork W2124400226 @default.
- W10393505 hasRelatedWork W2380769772 @default.
- W10393505 hasRelatedWork W2593041610 @default.
- W10393505 hasRelatedWork W2792313275 @default.
- W10393505 hasRelatedWork W3029498159 @default.
- W10393505 hasRelatedWork W3104949179 @default.
- W10393505 hasRelatedWork W3122465999 @default.
- W10393505 hasVolume "7" @default.
- W10393505 isParatext "false" @default.
- W10393505 isRetracted "false" @default.
- W10393505 magId "10393505" @default.
- W10393505 workType "article" @default.